Evidence map›Paper›PMID 32425229›Full record

ArticleGastroenterology2021

Focusing on Gastrointestinal Symptoms in COVID-19 Is Far From Enough.

Yuzhi Liu, Lingya Xiang, Kai Deng

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Gastroenterology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Gut distress and interventionFrontiers in public health · 2023
    Pooled it
  2. Review
  3. The roles of nausea and vomiting in COVID-19: did we miss something?Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi · 2021
    Review
  4. Review
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Yuzhi LiuDepartment of Gastroenterology and Sichuan, University-Oxford University Huaxi, Gastrointestinal, Cancer of West China Hospital Sichuan, University Chengdu, Sichuan, China.
Lingya XiangDepartment of Gastroenterology and Sichuan, University-Oxford University Huaxi, Gastrointestinal, Cancer of West China Hospital Sichuan, University Chengdu, Sichuan, China.
Kai DengDepartment of Gastroenterology and, COVID19 Medical Team (Hubei) of West China Hospital Sichuan University and, Medical Assistance Teams, East Branch of the Renmin Hospital of Wuhan University and, Sichuan University -Oxford University Huaxi Gastrointestinal, Cancer of West China Hospital Sichuan University, Chengdu, Sichuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Gastrointestinal DiseasesCase-Control StudiesDiarrheaHumansSARS-CoV-2United States

Identifiers

PMID32425229
PMCPMC7233219

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.